He retired from Pfizer Inc. in December 2006, where he was Senior Vice President for Science and Technology.
In 2002 and 2003, he also headed worldwide pharmaceutical research and development for Pfizer. Peter B. Corr. In addition to his work at Pfizer, Dr. Corr was Chairman of the Science & Regulatory Executive Committee of the Pharmaceutical Research and Manufacturers of America (PhRMA); Chairman of the PhRMA Foundation Board of Directors; and Chairman of the Hever Group, representing Chief Scientific Officers (CSOâs) across the European and U.S. based pharmaceutical industry. Dr. Peter B. Corr is Co-Founder and Managing General Partner of Auven Therapeutics Management LLLP. Corr, who received his doctorate from Georgetown University School of Medicine, spent 18 years as a researcher in molecular biology and pharmacology at Washington University in St. Louis.
… Dr. Corr retired from Pfizer Inc in December 2006 where he was Senior Vice President for Science and Technology. In 2004, Dr. Corr was named a William Pitt Fellow at Pembroke College, Cambridge University, Cambridge, U.K. Additionally, he is Chairman of the Board of the International Partnership for Microbicides and Chairman of the Board of Directors of the Critical Path Institute, in Tucson, Arizona; and serves on the boards of Furiex Pharmaceuticals, Inc.; Global Edit, Inc.; and the African Leadership Congress. In 2004, Dr. Corr was named a William Pitt Fellow at Pembroke College, Cambridge University, Cambridge, U.K. Dr. Peter Corr is Co-founder and General Partner of Auven Therapeutics Management LLLP. Contact information: peter@pbcorr.com. These include pieces of text that are stored on your computer or device.
Dr. Corr, who received his doctorate from Georgetown University School of Medicine, spent 18 years as a researcher in molecular biology and pharmacology at Washington University in St. Louis. Dr. Peter Corr is Co-founder and General Partner of Auven Therapeutics Management LLLP. In 2002 and 2003, he also headed worldwide pharmaceutical research and development for Pfizer. Dr. Corr is the recipient of numerous awards, including membership in the Alpha Omega Alpha National Medical Honorary Society, an Established Investigator Award from the American Heart Association, and a Research Career Development Award from the National Institutes of Health. He also served as Senior Vice President, Discovery Research, at Monsanto/Searle and then, President of Pharmaceutical Research and Development at Warner Lambert/Parke Davis.Dr. Dr. Peter B. Corr is Managing General Partner & Co-Founder at Auven Therapeutics Management LLLP, Chairman at ADC Therapeutics SARL, a Member at Alpha … Dr. Corr, who received his doctorate from Georgetown University School of Medicine, spent 18 years as a researcher in molecular biology and pharmacology at Washington University in St. Louis. Office: 908-546-6107 . This does not … He also served as Senior Vice President, Discovery Research, at Monsanto/Searle and then, President of Pharmaceutical Research and Development at Warner Lambert/Parke Davis. This site uses cookies and Google Analytics to improve navigation, minimize the need to reenter information previously entered on forms, personalize messages, and collect statistical information to improve site navigation and provide content of greatest interest to users. Filter by article type: A New Paradigm for Biomedical Research. He is a member of the National Council for Washington University School of Medicine and the Barnes Hospital Medical Center.Our patients are the heart of our company, and they, along with their families, friends and caregivers, are just as much members of the Imvax Team.By accessing our website or software provided by our third-party vendors, you consent to accept cookies, (including other identifiers). Applied Clinical Trials - Feb 01, 2005. His research has been published in more than 160 scientific manuscripts. Dr. Corr retired from Pfizer Inc. in December 2006 and served as its Senior Vice President of Science and Technology from July 2002 to 2006. His research has been published in more than 160 scientific manuscripts. Peter B. Corr, Ph.D., is a Non-Executive Director on the Board of Directors of ADC Therapeutics, as well as Co-Founder and Managing General Partner of Auven Therapeutics Management.
Detailed information on the use of cookies on this Site, and how you can decline them, is provided in our privacy policy. Dr. Corr is the recipient of numerous awards, including membership in the Alpha Omega Alpha National Medical Honorary Society, an Established Investigator Award from the American Heart Association, and a Research Career Development Award from the National Institutes of Health.
Co-Founder and Managing General Partner . Remote Digital Monitoring for Medical Product Development native1_300x100 . Dr. Corr is Co-Founder and Managing General Partner of Auven Therapeutics. He also served as Senior Vice President, Discovery Research, at Monsanto/Searle and then, President of Pharmaceutical Research and Development at Warner Lambert/Parke Davis.
Peter B. Gustavson School of Business is an internationally accredited business school located in Victoria, BC, on Canada's beautiful west coast. He served as a founding Board member on the Board of Directors of Furiex Pharmaceuticals, Inc. until the sale of the company in July, 2014. Peter B. Corr, MD, PhD. in 2007 and serves as its Co-Managing General Partner. When he left Washington University, Dr. Corr was Professor, Department of Medicine (Cardiology) and Professor, Department of Pharmacology and Molecular Biology. Workshop: RDCA-DAP 2020 Virtual Workshop Peter B. Corr works in the industry of Biotechnology, Pharmaceuticals, Healthcare. Peter B. Corr’s HQ phone number is (215) 485-0071 Which industry does Peter B. Corr work in?